• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[突尼斯某中心收治的慢性阻塞性肺疾病严重急性加重患者血液嗜酸性粒细胞计数作用的研究]

[Study of the role of blood eosinophil count in patients with severe acute exacerbation of chronic obstructive pulmonary disease hospitalized in a Tunisian Center].

作者信息

Saad Ahmed Ben, Khemakhem Rim, Mhamed Saousen Cheikh, Fahem Nesrine, Migaou Asma, Joobeur Samah, Rouatbi Naceur

机构信息

Service de Pneumologie et d'Allergologie, Hôpital Universitaire Fattouma Bourguiba, Rue 1 juin, 5000 Monastir, Tunisie.

出版信息

Pan Afr Med J. 2019 Nov 8;34:138. doi: 10.11604/pamj.2019.34.138.17392. eCollection 2019.

DOI:10.11604/pamj.2019.34.138.17392
PMID:33708307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906554/
Abstract

INTRODUCTION

There is a controversy over the relationship between blood eosinophil count (BEC) and the severity of chronic obstructive pulmonary disease (COPD) exacerbations. The purpose of our study was to determine the relationship between blood eosinophil count and multiple parameters in assessing the severity of serious acute exacerbation (AE) of obstructive pulmonary disease.

METHODS

We conducted a retrospective monocentric study of hospitalized patients with obstructive pulmonary disease treated between 2005 and 2015. We compared 2 groups of patients: G1(BEC+): BEC ≥ 200 cell/μl (103 cases, 20.4%), G2(BEC-): BEC < 200 cell/μl (403 patients: 79.6%).

RESULTS

A total of 506 subjects with obstructive pulmonary disease were included in the study. No significant difference between the two groups in age, gender, forced expiratory volume in one second (FEV1), and the number of AE/year (BEC+: 2.6, BEC-:2.5 AE/year; p = 0.48) was found. The analysis of the parameters of severity of serious AE showed no difference between the two groups in partial pressure of oxygen PaO2 measured on admission (60.5, 59.2 mmHg; p = 0.26), capnia (p=0.57), pH (p=0.74), C-reactive protein rate (mg/L) (82.7, 81; p = 0.89), leukocytosis (p = 0.36), non-invasive mechanical ventilation (5.8%, 6.5%; p = 0.81), invasive mechanical ventilation (p = 0.5),length of stay in hospital (9.7, 9 days; p = 0.21), mean time to next AECOPD (p = 0.32). Survival at 1 year was comparable between the two groups (94% vs 96%; Log Rank: 0.708).

CONCLUSION

Increased BEC in patients with COPD does not appear to have a negative effect on patients with severe AE. Despite the recent guidelines recommend to consider blood eosinophil count while making treatment decisions, the role and the prognostic interest of blood eosinophil count in patients with COPD could be population-dependent.

摘要

引言

血液嗜酸性粒细胞计数(BEC)与慢性阻塞性肺疾病(COPD)急性加重的严重程度之间的关系存在争议。我们研究的目的是确定在评估阻塞性肺疾病严重急性加重(AE)的严重程度时血液嗜酸性粒细胞计数与多个参数之间的关系。

方法

我们对2005年至2015年间接受治疗的住院阻塞性肺疾病患者进行了一项回顾性单中心研究。我们比较了两组患者:G1(BEC+):BEC≥200个细胞/μl(103例,20.4%),G2(BEC-):BEC<200个细胞/μl(403例患者:79.6%)。

结果

本研究共纳入506例阻塞性肺疾病患者。两组在年龄、性别、一秒用力呼气容积(FEV1)和每年AE次数方面无显著差异(BEC+组:2.6次/年,BEC-组:2.5次/年;p = 0.48)。对严重AE严重程度参数的分析显示,两组在入院时测得的氧分压PaO2(60.5,59.2 mmHg;p = 0.26)、二氧化碳潴留(p = 0.57)、pH值(p = 0.74)、C反应蛋白率(mg/L)(82.7,81;p = 0.89)、白细胞增多(p = 0.36)、无创机械通气(5.8%,6.5%;p = 0.81)、有创机械通气(p = 0.5)、住院时间(9.7,9天;p = 0.21)、至下一次AECOPD的平均时间(p = 0.32)方面无差异。两组1年生存率相当(94%对96%;对数秩检验:0.708)。

结论

COPD患者BEC升高似乎对严重AE患者没有负面影响。尽管最近的指南建议在做出治疗决策时考虑血液嗜酸性粒细胞计数,但血液嗜酸性粒细胞计数在COPD患者中的作用和预后意义可能因人群而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b7/7906554/b8df114790ef/PAMJ-34-138-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b7/7906554/b8df114790ef/PAMJ-34-138-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/69b7/7906554/b8df114790ef/PAMJ-34-138-g001.jpg

相似文献

1
[Study of the role of blood eosinophil count in patients with severe acute exacerbation of chronic obstructive pulmonary disease hospitalized in a Tunisian Center].[突尼斯某中心收治的慢性阻塞性肺疾病严重急性加重患者血液嗜酸性粒细胞计数作用的研究]
Pan Afr Med J. 2019 Nov 8;34:138. doi: 10.11604/pamj.2019.34.138.17392. eCollection 2019.
2
[Bronchial dilatations in patients with chronic obstructive pulmonary disease in a Tunisian center: effect on disease progression and prognosis].[突尼斯某中心慢性阻塞性肺疾病患者的支气管扩张:对疾病进展和预后的影响]
Pan Afr Med J. 2020 Oct 29;37:200. doi: 10.11604/pamj.2020.37.200.24448. eCollection 2020.
3
Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.慢性阻塞性肺疾病急性加重期血液嗜酸性粒细胞的稳定性及其与临床结局的关系:一项前瞻性队列研究。
Respir Res. 2021 Nov 24;22(1):301. doi: 10.1186/s12931-021-01888-5.
4
Blood Eosinophils and Outcomes in Severe Hospitalized Exacerbations of COPD.血液嗜酸性粒细胞与 COPD 严重住院加重期的结局。
Chest. 2016 Aug;150(2):320-8. doi: 10.1016/j.chest.2016.01.026. Epub 2016 Feb 3.
5
Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in China.中国一项基于人群的前瞻性队列研究:血嗜酸性粒细胞计数高的慢性阻塞性肺疾病患者的临床特征和 2 年结局。
Arch Bronconeumol. 2024 Jul;60(7):402-409. doi: 10.1016/j.arbres.2024.03.029. Epub 2024 Apr 18.
6
The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care.稳定期慢性阻塞性肺疾病患者血液嗜酸性粒细胞的稳定性:比利时初级保健中的回顾性研究。
BMC Pulm Med. 2020 Jul 22;20(1):200. doi: 10.1186/s12890-020-01234-3.
7
The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization.芬兰慢性阻塞性肺疾病(COPD)的负担:疾病严重程度和嗜酸性粒细胞计数对医疗资源利用的影响。
Int J Chron Obstruct Pulmon Dis. 2019 Oct 25;14:2409-2421. doi: 10.2147/COPD.S222581. eCollection 2019.
8
Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.贝那鲁肽治疗慢性阻塞性肺疾病和痰嗜酸性粒细胞增多症:一项随机、双盲、安慰剂对照、2a 期研究。
Lancet Respir Med. 2014 Nov;2(11):891-901. doi: 10.1016/S2213-2600(14)70187-0. Epub 2014 Sep 7.
9
The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.稳定期 COPD 中嗜酸性粒细胞恶化与嗜酸性粒细胞水平的关系。
BMC Pulm Med. 2021 Mar 2;21(1):74. doi: 10.1186/s12890-021-01443-4.
10
Variability of blood eosinophil count and prognosis of COPD exacerbations.血液嗜酸性粒细胞计数的变异性与慢性阻塞性肺疾病急性加重的预后
Ann Med. 2021 Dec;53(1):1152-1158. doi: 10.1080/07853890.2021.1949489.

引用本文的文献

1
Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study.急性加重及其表型对住院慢性阻塞性肺疾病患者临床结局的影响:一项横断面研究
Toxics. 2022 Nov 6;10(11):667. doi: 10.3390/toxics10110667.

本文引用的文献

1
Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)? CON.在慢性阻塞性肺疾病(COPD)急性加重期,我们是否应聚焦嗜酸性粒细胞以指导全身糖皮质激素治疗?反对观点。
Med Sci (Basel). 2018 Jun 8;6(2):49. doi: 10.3390/medsci6020049.
2
Blood eosinophil levels as a biomarker in COPD.血液嗜酸性粒细胞水平作为 COPD 的生物标志物。
Respir Med. 2018 May;138:21-31. doi: 10.1016/j.rmed.2018.03.016. Epub 2018 Mar 15.
3
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
慢性阻塞性肺疾病患者的血嗜酸性粒细胞计数阈值与加重。
J Allergy Clin Immunol. 2018 Jun;141(6):2037-2047.e10. doi: 10.1016/j.jaci.2018.04.010. Epub 2018 Apr 28.
4
Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.英国临床实践研究数据链中不同血液嗜酸性粒细胞水平的慢性阻塞性肺疾病患者的人口统计学和临床特征
COPD. 2018 Apr;15(2):177-184. doi: 10.1080/15412555.2018.1441275. Epub 2018 Mar 20.
5
Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials.慢性阻塞性肺疾病患者加重风险和布地奈德治疗反应的预测因素:三项随机试验的事后分析。
Lancet Respir Med. 2018 Feb;6(2):117-126. doi: 10.1016/S2213-2600(18)30006-7. Epub 2018 Jan 10.
6
Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease.血嗜酸性粒细胞计数与慢性阻塞性肺疾病加重的关系。
J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):944-954.e5. doi: 10.1016/j.jaip.2017.10.004. Epub 2017 Nov 15.
7
Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis.嗜酸性粒细胞增多与慢性阻塞性肺疾病的临床结局:一项荟萃分析。
Sci Rep. 2017 Oct 18;7(1):13451. doi: 10.1038/s41598-017-13745-x.
8
The 2017 Global Initiative for Chronic Obstructive Lung Disease Report and Practice Implications for the Respiratory Therapist.《2017年慢性阻塞性肺疾病全球倡议报告及对呼吸治疗师的实践意义》
Respir Care. 2017 Nov;62(11):1492-1500. doi: 10.4187/respcare.05402. Epub 2017 Sep 5.
9
Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.慢性阻塞性肺疾病患者血液嗜酸性粒细胞、临床特征与死亡率之间的关系
Int J Chron Obstruct Pulmon Dis. 2017 Jun 20;12:1819-1824. doi: 10.2147/COPD.S129787. eCollection 2017.
10
Eosinophils in COPD: just another biomarker?COPD 中的嗜酸性粒细胞:仅仅是另一种生物标志物吗?
Lancet Respir Med. 2017 Sep;5(9):747-759. doi: 10.1016/S2213-2600(17)30217-5. Epub 2017 Jun 7.